Inventor
FAN PEI
US35 patents
⚠️ This page may combine multiple inventors who share the name “FAN PEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
13 patentsUS11993648B2May 28, 2024
Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion
H LUNDBECK AS3 citations85
US11938185B2Mar 26, 2024
Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
H LUNDBECK AS3 citations85
US10975135B2Apr 13, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US10968268B2Apr 6, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US10954285B2Mar 23, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US12162936B2Dec 10, 2024
Methods of treatment with anti-PACAP antibodies
H LUNDBECK AS2 citations73
US11427631B2Aug 30, 2022
Anti-ACTH antibodies and use thereof
H LUNDBECK AS2 citations73
US11352409B2Jun 7, 2022
Anti-PACAP antibodies and uses thereof
H LUNDBECK AS2 citations73
US10981985B2Apr 20, 2021
Anti-PACAP antibodies
H LUNDBECK AS2 citations73
US12545725B2Feb 10, 2026
Anti-PACAP antibodies, nucleic acids and methods of making thereof
H LUNDBECK AS0 citations62
US12351627B2Jul 8, 2025
Anti-ACTH antibodies and use thereof
H LUNDBECK AS0 citations62
US12077581B2Sep 3, 2024
Anti-PACAP antibodies and uses thereof
H LUNDBECK AS0 citations62
US12428475B2Sep 30, 2025
Humanized anti-ACTH antibodies and use thereof
H LUNDBECK AS0 citations61
ALDERBIO HOLDINGS LLC
9 patentsUS9255154B2Feb 9, 2016
Anti-PCSK9 antibodies and use thereof
ALDERBIO HOLDINGS LLC36 citations92
US10844116B2Nov 24, 2020
Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia
ALDERBIO HOLDINGS LLC3 citations83
US10550180B2Feb 4, 2020
Anti-ACTH antibodies and use thereof
ALDERBIO HOLDINGS LLC2 citations73
US10227402B2Mar 12, 2019
Anti-NGF antibodies and anti-NGF antibody fragments
ALDERBIO HOLDINGS LLC1 citations73
US11117960B2Sep 14, 2021
Humanized anti-ACTH antibodies and use thereof
ALDERBIO HOLDINGS LLC2 citations72
US10259885B2Apr 16, 2019
Anti-PCSK9 antibodies and use thereof
ALDERBIO HOLDINGS LLC4 citations70
US9738713B2Aug 22, 2017
Methods of preventing or treating pain using anti-NGF antibodies
ALDERBIO HOLDINGS LLC1 citations63
US9067988B2Jun 30, 2015
Methods of preventing or treating pain using anti-NGF antibodies
ALDERBIO HOLDINGS LLC0 citations52
US9884909B2Feb 6, 2018
Anti-NGF compositions and use thereof
ALDERBIO HOLDINGS LLC1 citations50
ALDER BIOPHARMACEUTICALS INC
8 patentsUS10202435B2Feb 12, 2019
Anti-PACAP antibodies and uses thereof
ALDER BIOPHARMACEUTICALS INC9 citations92
US10913783B2Feb 9, 2021
Humanized anti-PACAP antibodies and uses thereof
ALDER BIOPHARMACEUTICALS INC4 citations83
US10981984B2Apr 20, 2021
Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion
ALDER BIOPHARMACEUTICALS INC3 citations82
US11254741B2Feb 22, 2022
Anti-PACAP antibodies
ALDER BIOPHARMACEUTICALS INC2 citations72
US10899834B2Jan 26, 2021
Anti-PACAP antibodies
ALDER BIOPHARMACEUTICALS INC2 citations72
US9688754B2Jun 27, 2017
Anti-ACTH antibodies and use thereof
ALDER BIOPHARMACEUTICALS INC2 citations72
US10544214B2Jan 28, 2020
Humanized anti-ACTH antibodies and use thereof
ALDER BIOPHARMACEUTICALS INC2 citations71
US10047157B2Aug 14, 2018
Humanized anti-ACTH antibodies and use thereof
ALDER BIOPHARMACEUTICALS INC2 citations71